LPL rs8176337: What Your Genotype Means
The rs8176337 variant is a single-nucleotide polymorphism located within the lipoprotein lipase (LPL) gene. Research has associated this variant with variations in body mass index (BMI) and lipid profile management in specific populations.
What each genotype means
Higher BMI association
Research in specific populations, such as those of Arab ancestry, has associated the G-allele of this variant with an increased body mass index. This variant is located in the lipoprotein lipase gene, which plays a key role in lipid metabolism and energy balance.
This genotype is common and found across various global populations.
Intermediate BMI association
Carrying one copy of the G-allele may be associated with variations in body mass index compared to those without the allele. Because this variant influences lipid profile management, individuals should focus on general healthy lifestyle practices and discuss any concerns about lipid levels with their healthcare provider.
This is a common genotype observed in many populations.
Typical BMI profile
This genotype does not carry the G-allele associated with increased body mass index in recent studies. It represents the baseline state for this specific intronic variant in the lipoprotein lipase gene.
This is a common genotype found in the general population.
Understanding the Variant
The rs8176337 variant is a genetic change located in the intronic region of the LPL gene. In genetics, an intronic variant sits within an intron, which is a non-coding section of a gene that is removed during the process of creating proteins. While introns do not directly code for the amino acid sequence of a protein, they can play critical roles in regulating how genes are expressed and how much protein is produced. Scientists study these variants to understand how subtle changes in non-coding DNA might influence complex human traits. Because this variant is located in a region that does not code for protein, its exact biological mechanism is still a subject of ongoing investigation. Researchers often look at these SNPs to see if they serve as markers for other functional changes nearby or if they influence the stability of the gene's messenger RNA.
The Role of the LPL Gene
The LPL gene provides instructions for making the lipoprotein lipase enzyme. This enzyme is essential for the breakdown of fats in the blood, specifically triglycerides, which are carried by lipoproteins like chylomicrons and very-low-density lipoproteins. By breaking down these fats, the enzyme helps provide energy to tissues such as muscle and adipose tissue. When the LPL enzyme functions optimally, it helps maintain healthy levels of triglycerides and high-density lipoprotein (HDL) cholesterol in the bloodstream. Because of its central role in lipid metabolism, variations in the LPL gene are frequently studied in the context of metabolic health, obesity, and cardiovascular risk. Understanding how this gene functions helps researchers piece together the complex puzzle of how our bodies process dietary fats and store energy, which is a fundamental aspect of metabolic homeostasis.
Research and Associations
Scientific research has explored the association between rs8176337 and various metabolic traits. A study published in 2025 identified a novel association between the G-allele of rs8176337 and increased BMI in a Kuwaiti population. Other studies have investigated the role of LPL variants in lipid levels, such as triglycerides and HDL cholesterol, in diverse groups, including African populations. It is important to note that the evidence for this specific variant is considered moderate and often population-specific. Genetic associations can vary significantly depending on the ancestry of the study participants, environmental factors, and lifestyle. While some studies show nominal associations with lipid traits, others may find different results, highlighting the complexity of genetic influences on metabolism. These findings should be viewed as statistical observations within specific cohorts rather than definitive predictors of an individual's health outcomes.
Population Frequency
The rs8176337 variant is considered a common SNP in the human population. Its frequency can vary across different ancestral groups, which is a standard observation in human genomics. Because it is common, many individuals carry at least one copy of the variant. Researchers use large-scale databases like gnomAD to track how often these alleles appear in different global populations. Understanding the frequency of a variant helps scientists determine if an association found in one group is likely to be replicated in others. If a variant is very common, it may have a smaller individual effect on a trait compared to rare variants, which can sometimes have more pronounced impacts. The widespread nature of this variant makes it a frequent subject of study in large-scale genetic association analyses.
Interpreting Your Information
Information about genetic variants like rs8176337 is intended for educational purposes and should not be used to diagnose or treat any medical condition. Genetic markers are only one piece of a much larger puzzle that includes diet, physical activity, environment, and other genetic factors. You cannot change your genotype, but understanding your genetic predispositions can be a tool for having more informed conversations with your healthcare provider. If you are concerned about your BMI, lipid levels, or cardiovascular health, it is essential to consult with a doctor or a registered dietitian. They can provide personalized guidance based on your clinical history and blood work. Never make changes to your diet or medication regimen based solely on genetic test results without professional medical supervision.
How common is this variant?
The rs8176337 variant is a common SNP found across various global populations, with allele frequencies varying by ancestry.
Frequently asked questions
What does it mean if I have the rs8176337 variant?
Having this variant simply means you carry a specific genetic sequence at this location in the LPL gene. It is a common variation and does not mean you will develop any specific health condition.
Can I change my LPL genotype?
No, your genotype is determined at conception and cannot be changed. However, lifestyle factors like diet and exercise can significantly influence how your genes affect your health.
Is rs8176337 a cause of obesity?
Genetic variants are rarely the sole cause of complex traits like obesity. While some studies show an association with BMI, obesity is a multifactorial condition influenced by many genes and environmental factors.
Should I get tested for this variant?
There is generally no clinical need to test for this specific variant. Most health-related decisions are based on clinical measurements like blood lipid panels and BMI rather than individual SNP results.
Sources & further reading
Educational information only, last refreshed 11/5/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs8176337?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in LPL
Missense variant in the lipoprotein lipase gene (Asn291Ser) associated with altered lipid profiles, increased risk of ischemic heart disease, and multivariate aging-related healthspan traits.
A functional gain-of-function variant in the LPL gene that disrupts a microRNA-410 seed site, leading to increased LPL expression, lower plasma triglycerides, higher HDL cholesterol, and potential protective effects against hepatocellular carcinoma in specific clinical contexts.
Lipoprotein lipase S447X (often referred to as S474X in older literature) variant affects triglyceride clearance.
A common variant in the LPL gene that helps lower triglyceride levels and provides protection against heart disease.
This variant in the lipoprotein lipase gene is studied for its interaction with diet and lifestyle interventions in the context of obesity management.